J06BB02
— Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins
Precautions:
Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Additional monitoring
This medicine is subject to additional monitoring.
Tetanus immunoglobulin is a product derived from human plasma, used for the prevention and treatment of tetanus, a serious infection caused by the bacterium Clostridium tetani. It contains specific antibodies against the tetanus toxin, neutralizing its effects and providing immediate protection.
It is used for post-exposure prophylaxis in individuals with contaminated wounds who are unvaccinated or have an incomplete vaccination history. It is also used to treat active tetanus by neutralizing the toxin.
It is administered via intramuscular injection, with the dose determined by the doctor based on the wound's severity or the patient's condition. Side effects are rare but may include pain at the injection site, mild fever, or allergic reactions.
Tetanus immunoglobulin provides temporary protection, and vaccination with tetanus toxoid is required for long-term immunity.
General data about TETANEA 1500UI / ml
Substance:
tetanus immunoglobulin
Date of latest medicines list:
01-03-2021
Product code:
W61098001
Concentration:
1500UI / ml
Pharmaceutical form:
solution for injection in pre-filled syringe
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Marketing authorisation
Manufacturer:
SANOFI PASTEUR SA - FRANTA
Holder:
CN UNIFARM S.A. - ROMANIA
Number:
460/2019/01
Shelf life:
3 years
Other substances similar to tetanus immunoglobulin